Subcutaneous BoNT/A Injection for Intractable Pain and Disability in Complex Regional Pain Syndrome: A Case Report

Toxins (Basel). 2022 Jun 16;14(6):411. doi: 10.3390/toxins14060411.

Abstract

We treated a 51-year-old woman with refractory Complex Regional Pain Syndrome type I (CRPS-I) involving her left hand and forearm with subcutaneous injections of BoNT/A. The injections were performed every 3 months, with a total of six treatments. Each treatment was able to effectively improve pain and motor impairment; however, the duration of the effect was limited to only a few months. BoNT/A could improve patients' quality of life with CRPS; however, extensive clinical studies are needed to determine its role in clinical practice.

Keywords: CRPS; botulinum toxin; disability; pain; subcutaneous injection.

Publication types

  • Case Reports

MeSH terms

  • Botulinum Toxins, Type A* / therapeutic use
  • Complex Regional Pain Syndromes* / drug therapy
  • Female
  • Humans
  • Injections, Subcutaneous
  • Middle Aged
  • Neuromuscular Agents* / therapeutic use
  • Pain, Intractable* / drug therapy
  • Quality of Life
  • Treatment Outcome

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A

Grants and funding

This research received no external funding.